Technology
Health
Pharmaceutical

Spring Bank Pharmaceuticals

$6.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.43%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell SBPH and other stocks, options, ETFs, and crypto commission-free!

About

Spring Bank Pharmaceuticals, Inc. engages in discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. Its products are used for the treatment of viral infections, inflammatory diseases, and certain cancers. Read More The company was founded by Douglas J. Jensen and Radhakrishnan P. Iyer on October 7, 2002 and is headquartered in Hopkinton, MA.

Employees
29
Headquarters
Hopkinton, Massachusetts
Founded
2002
Market Cap
113.78M
Price-Earnings Ratio
Dividend Yield
Average Volume
50.80K
High Today
$7.35
Low Today
$6.85
Open Price
$6.90
Volume
37.14K
52 Week High
$15.00
52 Week Low
$6.30

Collections

Technology
Health
Pharmaceutical
Banking
Therapy
Finance
2016 IPO
US

News

NasdaqApr 29

Spring Bank Pharmaceuticals Reports First Quarter 2019 Financial and Operational Results and Provides Corporate Update

ACHIEVE trial completed - inarigivir HBsAg reduction comparable to interferon but with significantly better tolerability profile Phase 2 co-administration study of inarigivir + nucleotide analogue fully enrolled - top-line results expected 2H'19 Study results to be presented at Science of HBV Cure meeting in Singapore demonstrating immune activation of inarigivir 400mg without systemic cytokine toxicity CATALYST Phase 2b trials launched - designed to demonstrate functional cure in HBV On track to ...

28

Earnings

-$0.85
-$0.60
-$0.36
-$0.11
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.